Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System
Chembio announced the submission to the FDA for a Clinical Laboratory Improvement Amendments waiver for the DPP HIV-Syphilis System.
Read MorePosted by Andy Lundin | Nov 28, 2022 | Sexually Transmitted Diseases |
Chembio announced the submission to the FDA for a Clinical Laboratory Improvement Amendments waiver for the DPP HIV-Syphilis System.
Read MorePosted by Chris Wolski | Nov 28, 2022 | Flow Cytometry, Lab Automation |
The ongoing clinical laboratory labor shortage is putting a strain on the U.S. healthcare system, but automation can help clinical labs cope.
Read MorePosted by Chris Wolski | Nov 23, 2022 | Molecular Diagnostics |
The October/November 2022 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
Read MorePosted by Chris Wolski | Nov 10, 2022 | Hematology & Serology |
Tampa General Hospital is the first in the nation to use an FDA-cleared rapid blood test to successfully evaluate patients for concussions.
Read MorePosted by Andy Lundin | Nov 3, 2022 | Company News |
Werfen is set to acquire Immucor, a privately held corporation with a strong presence in transfusion and transplant in vitro diagnostics.
Read More